Abpro Holdings shares surge 49.99% intraday as Goldman Sachs discloses 6.8% stake via SEC filing.

martes, 10 de febrero de 2026, 10:33 am ET1 min de lectura
ABP--
Abpro Holdings surged 49.99% intraday, with the company revealing that Goldman Sachs Group disclosed a 6.8% stake via a SEC Schedule 13G filing. Abpro Holdings specializes in developing next-generation antibody therapies using proprietary platforms DiversImmune and MultiMab for immuno-oncology and ophthalmology.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios